Comment améliorer les stratégies thérapeutiques en radiothérapie des carcinomes in situ dans les sous groupes à bas risque ?
Yazid BELKACEMI
Radiotherapeute, Paris, France
New User? Click here to register
Text generated by AI based on an exclusive interview, revised and reviewed by
Yazid BELKACEMI
Radiotherapeute, Paris, France
Dalila AHNOU
Fréderique PENAULT LORCA
Chairwoman of the Pathology department, University Hospital, Clermont Ferrand, France
Copyright © 2026 - BCU